Reliability of Sentinel Lymph Node Mapping With Biopsy for Head and Neck Cutaneous Melanoma
Authors:
- Brian NussenbaumBNBrian Nussenbaum
- Riley S. ReesRRRiley S. Rees
- Jennifer SchwartzJSJennifer Schwartz
- Timothy M. JohnsonTJTimothy M. Johnson
- Carol R. BradfordCBCarol R. Bradford
Open Access
- 1 January 2003
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Otolaryngology–Head & Neck Surgery
- Vol. 129 (1) , 61-65
Abstract
NUMEROUS QUESTIONS surround the management of head and neck cutaneous melanoma, especially with respect to the role for elective treatment of regional nodal basins. Prospective randomized trials have failed to demonstrate a survival benefit for patients with melanoma undergoing elective lymphadenectomy.1,2 While nodal status is clearly recognized as the most significant prognostic factor for patients diagnosed with cutaneous melanoma, only 10% to 20% of patients present with occult lymph node metastasis. This risk for nodal metastasis increases as primary tumor thickness increases. Lesions less than 1 mm thick are associated with a less than 5% rate of regional metastasis, while lesions thicker than 4 mm are associated with a 30% to 50% rate of nodal involvement.3,4Keywords
This publication has 24 references indexed in Scilit:
- A Prospective Study of Intraoperative Lymphatic Mapping for Head and Neck Cutaneous MelanomaJAMA Otolaryngology–Head & Neck Surgery, 2002
- Prognostic Factors Analysis of 17,600 Melanoma Patients: Validation of the American Joint Committee on Cancer Melanoma Staging SystemJournal of Clinical Oncology, 2001
- Sentinel Lymph Node Biopsy for Melanoma: Controversy Despite Widespread AgreementJournal of Clinical Oncology, 2001
- Validation of the Accuracy of Intraoperative Lymphatic Mapping and Sentinel Lymphadenectomy for Early-Stage MelanomaAnnals of Surgery, 1999
- Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomized trialCancer/Radiothérapie, 1999
- Multi-Institutional Melanoma Lymphatic Mapping Experience: The Prognostic Value of Sentinel Lymph Node Status in 612 Stage I or II Melanoma PatientsJournal of Clinical Oncology, 1999
- Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma.Journal of Clinical Oncology, 1998
- Efficacy of an Elective Regional Lymph Node Dissection of 1 to 4 mm Thick Melanomas for Patients 60 Years of Age and YoungerAnnals of Surgery, 1996
- Prediction of potential metastatic sites in cutaneous head and neck melanoma using lymphoscintigraphyThe American Journal of Surgery, 1995
- Technical Details of Intraoperative Lymphatic Mapping for Early Stage MelanomaArchives of Surgery, 1992